#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA1614236	Functional	PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory)	Influenza A virus (A/WSN/1933(H1N1))	32,268	ALA1201862	assay format	PubChem BioAssays
2.	ALA1072832	Binding	Activity at human recombinant CES1 expressed in baculovirus-infected Spodoptera frugiperda Sf21 cells assessed as substrate hydrolysis by fluorescence assay	Homo sapiens	39	ALA1157682	cell-based format	Scientific Literature
3.	ALA1794345	Functional	PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]	Plasmodium falciparum	170,142	ALA1201862	organism-based format	PubChem BioAssays
4.	ALA1794401	Functional	PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962]		91,504	ALA1201862	assay format	PubChem BioAssays
5.	ALA1794580	Functional	PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]	Plasmodium falciparum	130,890	ALA1201862	organism-based format	PubChem BioAssays
6.	ALA1909163	Binding	DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4)	Cavia porcellus	871	ALA1909046	tissue-based format	DrugMatrix
7.	ALA1909164	Binding	DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4)		871	ALA1909046	cell membrane format	DrugMatrix
8.	ALA1909165	Binding	DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid)	Oryctolagus cuniculus	871	ALA1909046	tissue-based format	DrugMatrix
9.	ALA1909166	Binding	DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH)		871	ALA1909046	cell membrane format	DrugMatrix
10.	ALA1909167	Binding	DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH)		871	ALA1909046	cell membrane format	DrugMatrix
11.	ALA1909168	Binding	DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH)		871	ALA1909046	cell membrane format	DrugMatrix
12.	ALA1909169	Binding	DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine)		871	ALA1909046	cell-based format	DrugMatrix
13.	ALA1909170	Binding	DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine)		871	ALA1909046	cell membrane format	DrugMatrix
14.	ALA1909171	Binding	DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine)		871	ALA1909046	cell membrane format	DrugMatrix
15.	ALA1909172	Binding	DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine)		871	ALA1909046	cell membrane format	DrugMatrix
16.	ALA1909173	Binding	DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine)		871	ALA1909046	cell membrane format	DrugMatrix
17.	ALA1909174	Binding	DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine)		871	ALA1909046	cell membrane format	DrugMatrix
18.	ALA1909175	Binding	DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)		871	ALA1909046	cell membrane format	DrugMatrix
19.	ALA1909176	Binding	DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)		871	ALA1909046	cell membrane format	DrugMatrix
20.	ALA1909177	Binding	DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine)		871	ALA1909046	cell membrane format	DrugMatrix